Home News & Events Events Events Filter events Filter events by clicking within the ‘Category’ drop-down list. Category - Any -IndustryWebinarsWorkshop Previous 1 2 In this section In this section Press releases In the News Mediakit Facts and figures ICON spokespeople Awards Events Industry events Webinars Workshops Webinars Social media Connect with us Contact us Submit proposal request Update Email Preferences Global office locator ICON on social media Related Information Webpage Webinars Webpage Industry Events Webpage Workshops What’s happening in ICON ICON Plc How do you choose the right control group for organ impairment trials? Despite consensus on the need for demographic similarity between test and control groups, practical guidance is surprisingly scarce. Too often, sele... 14 Nov View post View webpage ICON Plc The number of clinical trials using digital endpoints has doubled every 3 years since 2015. The industry is seeing that leveraging DHTs in trials offers: - Faster data collection - Greater sensitivity to treatment effec... 14 Nov View post View webpage ICON Plc Risk-based strategies aren’t optional, they’re essential. ICON’s Victoria DeVeaugh-Geiss shares six principles sponsors should consider building into their clinical trial operations. Read the blog https://ow.ly/i5kG50Xok... 14 Nov View post View webpage ICON Plc Did you know LinkedIn has a feature that allows you to privately express your interest in working with ICON? By clicking the 'I'm interested' button on our company page, you can signal to our Talent Acquisition team tha... 14 Nov View post View webpage ICON Plc Regulators, patients, and sponsors are all asking: Does this treatment improve life beyond the numbers? And in obesity trials, the number on the scale is only a portion of what patients care about. Learn more about wh... 14 Nov View post View webpage ICON Plc This World Diabetes Day, the theme ‘Diabetes and the workplace’ reminds us that 70% of people living with diabetes are of working age. At ICON, we recognise the urgency of advancing therapies that improve outcomes for t... 14 Nov View post View webpage ICON Plc By 2050, the number of people living with diabetes is projected to rise to 853 million. In the past 5 years, ICON has conducted 198 metabolic studies involving 50,000+ patients and healthy volunteers at 8,600+ sites, inc... 14 Nov 3 View post View webpage ICON Plc Flexible, risk-based monitoring strategies are transforming global trial delivery. ICON’s new whitepaper shows how smarter oversight improves quality, reduces cost and accelerates timelines. Download now: https://www.ico... 14 Nov 1 View post View webpage ICON Plc Early clinical trial designs—especially first-in-human (FIH) studies—are increasingly tailored to the unique needs of specific therapeutic areas. In neurodegenerative diseases, there is a growing shift toward flexible an... 14 Nov 4 View post View webpage ICON Plc Customer advocacy is not a trend, it’s a transformation. It represents a shift from service to stewardship and from expertise to empathy. It’s about recognising that behind every clinical milestone, every regulatory su... 13 Nov View post View webpage ICON Plc In the dynamic world of life sciences, the consultancy sector is undergoing a transformation as cost pressures increase, speed to market needs accelerate and technology permeates every aspect. Against this backdrop, clie... 13 Nov 2 View post View webpage ICON Plc Use Journals & Congresses to sort over 10,000 journals and congresses by submission date and lead times. Get your answer quickly so you can focus on your work. See how easy it is for yourself & request a demo. https://ow... 13 Nov 1 View post View webpage
